Litcius/Paper detail

Unfavorable immunotherapy plus tyrosine kinase inhibition outcome of metastatic renal cell carcinoma after radical nephrectomy with increased ADAM9 expression

Xianglai Xu, Ying Wang, Zhaoyi Chen, Yanjun Zhu, Jiajun Wang, Jianming Guo

2022Immunogenetics10 citationsDOI

Topics & Concepts

ImmunotherapyMedicineRenal cell carcinomaInternal medicineCD8Flow cytometryBiologyCancer researchOncologyImmune systemImmunologyRenal cell carcinoma treatmentCancer Immunotherapy and BiomarkersBladder and Urothelial Cancer Treatments